£600K
The funding round was backed by the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group.
I
ImmuONE
ImmuONE develops human lung tissue models to replace animal testing in drug safety evaluations.
United Kingdom—Founded 2019
£2.6MTotal raised
ImmuONE is a British biotech startup that develops advanced human lung models for preclinical safety testing. The company provides animal-free alternatives for evaluating drugs, chemicals, and consumer products.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from ImmuONE's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
AM
Abigail Martin
Co-founder
Abigail is the co-founder and CEO of ImmuONE. She previously held research and entrepreneurial roles at the SETsquared Partnership, the National Centre for the Replacement, Refinement and Reduction of Animals in Research, and the University of Hertfordshire.
LinkedInVH
Victoria Hutter
Professor
Investors
- £600K
- £2.0M
Funding history
£2.0M
The funding will support new laboratories in Stevenage and headquarters in Milton Keynes alongside team expansion.